External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

Obesity Week 2026

November 14 - November 17

Washington, D.C., USA

obesityweek.org

We will be contributing to topics related to

Metabolism Cardiovascular

Add to calendar

Agenda

Medical Materials

12:30 AM

Duration 60mins Washington, D.C., USA

Two Phase 3 Studies Evaluating Enicepatide in People With Overweight/Obesity With or Without T2D

Naveed Sattar, W. Timothy Garvey, Donna Ryan, Ildiko Lingvay, Jennifer Damman, Esther Shearer-Kang, Ying Liu, Jeffrey R. Willis, Manu V.Chakravarthy

Cardiovascular - Metabolism | Obesity

Notify me

Add to calendar

07:30 PM

Duration 60mins Washington, D.C., USA

Petrelintide Co-Administered With Enicepatide in People Living With Obesity or Overweight (ZYNERGY)

Azadeh Houshmand-Oeregaard, Karen Bonefeld, Ólöf Thórisdóttir, Almut Mecke, Rui Zhu, Rasmus Juul Kildemoes, Dayana Flores, Tina Zinck, Smita Kshirsagar, Stine Just Maarbjerg

Cardiovascular - Metabolism | Obesity

Notify me

Add to calendar

10:00 PM

Duration 15mins Washington, D.C., USA

Effects of Enicepatide (CT-388) on Body Composition in Adults With Overweight or Obesity

Harold Bays, Dan Lender, Carel Le Roux, Muhamed Barakovic, Alexandra Steinberg, Ying Liu, Jeffrey R Willis, Xuwei Hou, Esther Shearer-Kang, Diego Rebella, Ildiko Lingvay

Cardiovascular - Metabolism | Obesity

Notify me

Add to calendar

Coming soon

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.